Business Description

Bruker Corp
NAICS : 334516
SIC : 3826
ISIN : US1167941087
Share Class Description:
BRKR: Ordinary SharesDescription
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives a majority of its revenue from Europe.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.3 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 1.01 | |||||
Debt-to-EBITDA | 2.25 | |||||
Interest Coverage | 29.72 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.61 | |||||
Beneish M-Score | -1.82 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 8.6 | |||||
3-Year EBITDA Growth Rate | 13.5 | |||||
3-Year EPS without NRI Growth Rate | 18.6 | |||||
3-Year FCF Growth Rate | 2.7 | |||||
3-Year Book Growth Rate | 8.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 9.89 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.98 | |||||
9-Day RSI | 69.9 | |||||
14-Day RSI | 66.88 | |||||
6-1 Month Momentum % | -22.05 | |||||
12-1 Month Momentum % | -13.63 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.89 | |||||
Quick Ratio | 1.04 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 225.96 | |||||
Days Sales Outstanding | 59.62 | |||||
Days Payable | 48.11 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Dividend Payout Ratio | 0.09 | |||||
3-Year Dividend Growth Rate | 7.7 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.34 | |||||
3-Year Average Share Buyback Ratio | 1.6 | |||||
Shareholder Yield % | 3.69 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 51.41 | |||||
Operating Margin % | 17.19 | |||||
Net Margin % | 11.32 | |||||
FCF Margin % | 7.31 | |||||
ROE % | 28.13 | |||||
ROA % | 8.68 | |||||
ROIC % | 12.62 | |||||
ROC (Joel Greenblatt) % | 41.19 | |||||
ROCE % | 16.39 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 31.32 | |||||
Forward PE Ratio | 24.33 | |||||
PE Ratio without NRI | 26.5 | |||||
Shiller PE Ratio | 51.85 | |||||
Price-to-Owner-Earnings | 52.85 | |||||
PEG Ratio | 1.84 | |||||
PS Ratio | 3.56 | |||||
PB Ratio | 8.2 | |||||
Price-to-Tangible-Book | 27.86 | |||||
Price-to-Free-Cash-Flow | 48.72 | |||||
Price-to-Operating-Cash-Flow | 31.76 | |||||
EV-to-EBIT | 23.3 | |||||
EV-to-Forward-EBIT | 17.33 | |||||
EV-to-EBITDA | 18.91 | |||||
EV-to-Forward-EBITDA | 14.27 | |||||
EV-to-Revenue | 3.64 | |||||
EV-to-Forward-Revenue | 3.27 | |||||
EV-to-FCF | 49.8 | |||||
Price-to-Projected-FCF | 2.9 | |||||
Price-to-Median-PS-Value | 1.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.79 | |||||
Price-to-Graham-Number | 5.73 | |||||
Earnings Yield (Greenblatt) % | 4.29 | |||||
FCF Yield % | 2.19 | |||||
Forward Rate of Return (Yacktman) % | 16.48 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BRKR
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bruker Corp Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 2,818.4 | ||
EPS (TTM) ($) | 2.17 | ||
Beta | 1.14 | ||
Volatility % | 29.49 | ||
14-Day RSI | 66.88 | ||
14-Day ATR ($) | 1.914231 | ||
20-Day SMA ($) | 64.027 | ||
12-1 Month Momentum % | -13.63 | ||
52-Week Range ($) | 53.79 - 84.84 | ||
Shares Outstanding (Mil) | 138.41 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bruker Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bruker Corp Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Bruker Corp Frequently Asked Questions
What is Bruker Corp(BRKR)'s stock price today?
The current price of BRKR is $67.97. The 52 week high of BRKR is $84.84 and 52 week low is $53.79.
When is next earnings date of Bruker Corp(BRKR)?
The next earnings date of Bruker Corp(BRKR) is 2024-02-09 Est..
Does Bruker Corp(BRKR) pay dividends? If so, how much?
The Dividend Yield %  of Bruker Corp(BRKR) is 0.29% (As of Today), Highest Dividend Payout Ratio of Bruker Corp(BRKR) was 0.28. The lowest was 0.09. And the median was 0.13. The  Forward Dividend Yield % of Bruker Corp(BRKR) is 0.29%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |